Lukas Rob

126 papers receiving 4.3k citations

Lukas Rob's Hit Papers

ENGOT-en11/GOG-3053/KEYNOTE-B21: a randomised, double-blind, phase III study of pembrolizumab or placebo plus adjuvant chemotherapy with or without radiotherapy in patients with newly diagnosed, high-risk endometrial cancer 2024 · 64 citations
640+3+7Years since publication50100150200250

Peers

Lukas Rob
Comparison fields: 5 of 88
  • Obstetrics and Gynecology 1.5k
  • Oncology 1.1k
  • Reproductive Medicine 397
  • Immunology 626
  • Cancer Research 284
Replace Frédéric Goffin with:
Frédéric Goffin Belgium
Cor Doede de Kroon Netherlands
Bor‐Ching Sheu Taiwan
Wataru Yamagami Japan
Kay J. Park United States
Joachim Rom Germany
Masami Fujita Japan
Marco Petrillo Italy
Tsunehisa Kaku Japan
J. Baptist Trimbos Netherlands
Lukas Rob relative to Frédéric Goffin Belgium Frédéric Goffin's profile →
Citations per field
00.5×2×3×4.0×
Frédéric Goffin · 1×
Citations per year

Countries citing papers authored by Lukas Rob

Since Specialization
Citations

This map shows the geographic impact of Lukas Rob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas Rob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas Rob more than expected).

Fields of papers citing papers by Lukas Rob

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lukas Rob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas Rob. The network helps show where Lukas Rob may publish in the future.

Co-authors

The 25 scholars most cited alongside Lukas Rob, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lukas Rob Line = papers co-authored together Lukas Rob links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 137 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2011351
2 2018271
3
Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy
Hit paper breakdown →
2015268
4 2010215
5 2018159
6 2014155
7 2017148
8 2008134
9 2005133
10 2015129
11 2010107
12 201098
13 202098
14 201297
15 200789
16 200983
17 201479
18 200875
19 202470
20 201969

About Lukas Rob

Lukas Rob is a scholar working on Obstetrics and Gynecology, Reproductive Medicine, Oncology, Epidemiology and Immunology, having authored 137 papers that have together received 4.5k indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (49 papers), Ovarian cancer diagnosis and treatment (22 papers), Cervical Cancer and HPV Research (18 papers), Immunotherapy and Immune Responses (8 papers), Pregnancy and Medication Impact (7 papers), Genital Health and Disease (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). The work is most often cited by research in Obstetrics and Gynecology (1.5k citations), Oncology (1.1k citations), Reproductive Medicine (397 citations), Immunology (626 citations) and Cancer Research (284 citations). Lukas Rob has collaborated with scholars based in Czechia, Belgium and Netherlands. Frequent co-authors include Helena Robová, Petr Škapa, Michael Jiri Halaska, Marek Pluta, Radek Špíšek, Jitka Palich Fucikova, Martin Hrehorcak, Jiřina Bartůňková, Anna Fialová and Tomáš Brtnický. Their work appears in journals such as International Journal of Gynecological Cancer, Gynecologic Oncology, Journal for ImmunoTherapy of Cancer, International Journal of Cancer and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact